The peptide prediction ecosystem is exploding 🤯🧬

A large-scale review of peptide activity prediction tools reveals rapid growth, reproducibility issues and emerging trends in ML-based peptide bioinformatics.

Keywords

peptides, machine learning, deep learning, bioinformatics, AMP, reproducibility, prediction tools

---

📌 Project highlights

• 🧬 Reviews 140 peptide prediction tools
  
• 🤖 Covers AMP, anticancer, antiviral & more
  
• 📊 Tracks rise of deep learning in peptide ML
  
• ⚠️ Reveals major reproducibility crisis
  
• 🌐 Provides curated peptide prediction resource database

---

🎉 New paper out! This one tackles a very meta problem:

👉 there are now SO MANY peptide predictors that choosing one became a challenge itself 😄

👉 The dynamic landscape of peptide activity prediction

---

🔗 Explore the peptide prediction landscape

• 🌐 Tool list: https://biogenies.info/peptide-prediction-list/

👉 one place to browse the chaotic peptide prediction universe 🌌

---

🎧 Audio summary

Antimicrobial predictors. Anticancer predictors. Antiviral predictors.
Deep learning everywhere. Broken web servers. Missing code 😅

👉 Here’s a short audio overview 🎧 explaining what is happening in peptide ML:

🔬 What is this about?

Peptides can do a lot:

• 🦠 antimicrobial activity
  
• 🎯 anticancer effects
  
• 🧠 blood–brain barrier penetration
  
• 🔥 anti-inflammatory activity
  
• 🧬 anti-amyloid interactions

---

Because of that:

👉 researchers keep building ML predictors for peptide activity.

And the field exploded 🚀

---

📊 The scale of the problem

This review identified:

• 140 peptide prediction tools
• published between 2009–2022

---

Activities included:

• antimicrobial peptides (AMPs)
  
• anticancer peptides
  
• antiviral peptides
  
• antifungal peptides
  
• cell-penetrating peptides
  
• blood–brain barrier peptides

…and many more 😅

---

⚠️ The core problem

Too many tools.

Too many datasets.

Too many inconsistent definitions.

---

Example:

👉 “AMP” sometimes means:

• antibacterial only ❌
  
• all antimicrobial peptides ✅

depending on the paper

---

And this creates:

• benchmark bias
  
• incompatible predictors
  
• reproducibility nightmares

---

🧠 What they analyzed

📊 Trends in peptide ML

The study explored:

• predictive activities
  
• ML architectures
  
• citations
  
• reproducibility
  
• web server availability

---

🤖 Deep learning explosion

Before 2018:

👉 basically no deep models.

By 2021:

👉 almost HALF of predictors used deep learning

---

🧬 Most common activities

Top prediction targets were:

• anticancer peptides
  
• antimicrobial peptides
  
• antiviral peptides

👉 AMP and anticancer prediction dominate the field.

---

⚙️ Most common ML models

The kings of peptide ML:

• 🌲 Random Forests
  
• 📈 Support Vector Machines
  
• 🤖 Deep Learning architectures

---

Interestingly:

👉 deep learning is popular…

BUT not always clearly better.

---

🔍 Key insights

⚠️ Reproducibility crisis 🚨

This was probably the biggest finding.

Among 111 analyzed tools:

• only 38 met minimum reproducibility requirements
  
• only 9 achieved “gold standard” reproducibility

---

Meaning:

❌ missing code
❌ missing datasets
❌ broken workflows

---

👉 and yes…

many web servers were dead 😅

---

🌐 Web servers matter more than reproducibility

Surprisingly:

👉 tools with active web servers got more citations

even if they were less reproducible

---

This creates a weird incentive:

👉 flashy website > robust science

---

🤖 Deep learning hype is real

Deep models became more cited over time.

BUT:

the review highlights that for AMP prediction:

👉 DL often does not outperform shallow models

---

🚀 Why this matters

🧠 For peptide therapeutics

Peptide ML is now central for:

• antimicrobial discovery
  
• anticancer peptides
  
• neurodegeneration research

---

⚠️ For bioinformatics

The field needs:

• better standards
  
• fair benchmarking
  
• reproducibility
  
• maintenance of tools

---

🌍 For users

This review acts as:

👉 a navigation map for peptide prediction tools.

---

💚 BioGenies perspective

This paper is basically:

👉 “someone had to say it” 😄

The peptide ML ecosystem is:

• powerful
  
• exciting
  
• rapidly growing

BUT ALSO:

• fragmented
  
• biased
  
• difficult to reproduce

And honestly:

👉 this paper connects almost ALL our work together:

• AmpGram
  
• CancerGram
  
• AMP benchmarking
  
• peptide therapeutics
  
• reproducibility standards

---